Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2005

01-05-2005 | Poster presentation

A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)

Authors: A Bensalem, K Bouzid

Published in: Breast Cancer Research | Special Issue 1/2005

Login to get access

Excerpt

We conducted a phase II trial to define the safety, the efficacy, the pathological response rate and survival associated with four cycles DXR-GMZ administered every 3 weeks followed by surgery, then four cycles of FAC50 as a primary therapy in MBC. …
Metadata
Title
A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
Authors
A Bensalem
K Bouzid
Publication date
01-05-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1244

Other articles of this Special Issue 1/2005

Breast Cancer Research 1/2005 Go to the issue

Oral presentation

Gene expression profile-based predictors of response to chemotherapy

Oral presentation

The role of gene expression profiling by microarray analysis for prognostic classification of breast cancer

Oral presentation

Circulating tumor cells and novel biomarkers for prognostic and biological of breast cancer

Oral presentation

Methods for gene expression profiling in clinical trials for breast cancer

Oral presentation

Oral vinorelbine in metastatic breast cancer

Oral presentation

Sentinel node biopsy versus conventional axillary dissection in clinically node-negative breast cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits